Teva Pharmaceutical reported 225M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aspen Pharmacare APN:SJ 351M 129M
Guangzhou Baiy 600332:CH 106.44M 2.18M
Kalbe Farma Tbk Pt KLBF:IJ 9.33B 279.01M
Richter Gedeon RICHT:HB 4.76B 4.59B
Sh Fosun Pharma 600196:CH CH 206.95M 16.54M
Teva Pharmaceutical TEVA:IT 225M 13M